Risk Assessment In Drug Development For Symptomatic Indications: A Framework For The Prospective Exclusion Of Unacceptable Cardiovascular Risk
CLINICAL PHARMACOLOGY & THERAPEUTICS（2006）
Key words
risk assessment,pharmacology,drug development
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined